Clampdown of inflammation in aging and anticancer therapies by limiting upregulation and activation of GPCR, CXCR4
Aging and Inflammation: Targeting a cellular receptor reduces the deleterious inflammation during aging and anti-cancer therapy A sensing protein that is increased in response to DNA damage can be targeted to reduce inflammation and collateral damage during anti-cancer therapy and aging. Scientists...
Guardado en:
Autores principales: | Raji R. Nair, Shreyas V. Madiwale, Deepak Kumar Saini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56efcd0e49494735bd73ee10009830ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Upper limit of the normal range for thyrotropin-stimulating hormone is higher with increasing age [Corrigendum]
por: Jolobe OM
Publicado: (2013) -
The GSK3β-β-catenin-TCF1 pathway improves naive T cell activation in old adults by upregulating miR-181a
por: Zhongde Ye, et al.
Publicado: (2021) -
Is it necessary to cure prostate cancer when it is possible? (Understanding the role of prostate inflammation resolution to prostate cancer evolution)
por: Ronald E Wheeler
Publicado: (2007) -
Age-related macular degeneration and the aging eye
por: Rita Ehrlich, et al.
Publicado: (2008) -
Immunosupportive therapies in aging
por: Tamas Fülöp, et al.
Publicado: (2007)